![heading-Nerlynx-Neratinib--HER2-Breast-Cancer-2](/sites/nerlynx/files/2021-06/Heading-4.png)
Possible clinical scenarios
NERLYNX® can be used as extended adjuvant therapy for selected patients*37
![Nerlynx-Neratinib--HER2+/HR+ early breast cancer- Adjuvant treatment history](/sites/nerlynx/files/2023-03/Sans%20titre%20website.png)
Summary of the possible clinical scenarios taking into account therapeutic advances and acknowledging the different levels of evidence for NERLYNX® use.37